JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Dynatrace Files Registration Statement for Proposed Initial Public Offering
-
JMP Securities Downgrades NorthStar Realty Europe Corp. (NRE) to Market Perform
-
Tesla (TSLA)'s US Shipments Prove 1Q was Not Indicative of Demand Levels, Reit MP at JMP
-
Sorrento Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Warrants
-
Aerie Pharma (AERI) PT Lowered to $58 at JMP Securities
-
Aclaris Therapeutis (ACRS) PT Lowered to $7 at JMP Securities
-
ClareMedica Health Partners and Beecken Petty O’Keefe & Company Form Partnership With Equity Investment
-
NorthStar Realty Europe Corp. (NRE) Bid In Line with JMP's FV Estimate
-
Tesla (TSLA) Model 3 Demand Is Being Underestimated By The Street, Reit JMP Securities
-
JMP Securities Downgrades WageWorks (WAGE) to Market Perform
-
Cambium Networks Corporation Announces Closing of Initial Public Offering
-
Cambium Networks Corporation Announces Closing of Initial Public Offering
-
Sorrento Therapeutics (SRNE) Prices 8.33M Share Common Offering and Warrants Offering at $3/Sh
-
Sorrento Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
-
Sorrento Therapeutics (SRNE) Announces Proposed Common Share and Warrants Offering
-
Sorrento Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
-
MindTouch Knowledge Management Solution Helps 8x8 Lay Groundwork for Best-in-Class Self-Service
-
ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL ANNOUNCES PRICING OF $35 MILLION PUBLIC OFFERING OF ORDINARY SHARES
-
ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL ANNOUNCES PRICING OF $35 MILLION PUBLIC OFFERING OF ORDINARY SHARES
-
The RMR Group Inc. (RMR) Prices 7.94M Share Common Offering at $40/Sh
-
Gamida Cell Ltd. (GMDA) Prices 7M Share Common Offering at $5/Sh
-
Alexander & Baldwin to Attend the 2019 JMP Securities Conference
-
Gamida Cell Announces Pricing of $35 Million Public Offering of Ordinary Shares
-
RMR Client Companies Price Offering of 7,942,245 Common Shares of The RMR Group Inc.
-
Cambium Networks Corp. (CMBM) Prices 5.8M Share IPO at $12/Sh
-
Cambium Networks Corporation Announces Pricing of Initial Public Offering
-
Cambium Networks Corporation Announces Pricing of Initial Public Offering
-
JMP Securities Reiterates Market Outperform Rating on Minerva Neurosciences (NERV)
-
ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL ANNOUNCES LAUNCH OF PROPOSED PUBLIC OFFERING OF ORDINARY SHARES
-
ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL ANNOUNCES LAUNCH OF PROPOSED PUBLIC OFFERING OF ORDINARY SHARES
-
Gamida Cell (GMDA) Announces Launch of $30M Proposed Public Offering of Ordinary Shares
-
Gamida Cell Announces Launch of Proposed Public Offering of Ordinary Shares
-
Senior Housing Properties Trust Attending 2019 JMP Securities Boston Real Estate Conference on Thursday, June 27th
-
NHI to Participate in 2019 JMP Securities Boston Real Estate Forum
-
Intra-Cellular Therapies to Present at JMP Securities Life Sciences Conference
-
JMP Group Announces Addition of Raj Dayalan to Investment Banking Division
-
AquaVenture Holdings (WAAS) PT Raised to $31 at JMP Securities
-
Invitation Homes (INVH) PT Raised to $30 at JMP Securities
-
JMP Group Announces Partial Redemption of 8.00% Senior Notes Due 2023
-
Idera Pharmaceuticals to Present at the 2019 JMP Securities Life Sciences Conference
-
Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
-
Motus GI to Present at the JMP Securities Life Sciences Conference
-
iCAD to Participate in the JMP Securities Life Sciences Conference and Piper Jaffray Heartland Summit
-
Sutro Biopharma to Present at the JMP Securities Life Sciences Conference
-
JMP Group Announces Results of Self-Tender Offer
-
Cree (CREE) PT Raised to $81 at JMP Securities
-
CrowdStrike Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
CrowdStrike Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Apollo Endosurgery, Inc. to Present at the JMP Securities 2019 Life Sciences Conference
-
Aclaris Therapeutics to Present at the 2019 JMP Securities Life Sciences Conference

